# A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants

> **NCT06316973** · PHASE1 · COMPLETED · sponsor: **Clear Scientific, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Substance Use Disorders
- Methamphetamine Abuse
- Methamphetamine Intoxication

## Interventions

- **DRUG:** CS-1103
- **DRUG:** Sterile Saline

## Key facts

- **NCT ID:** NCT06316973
- **Lead sponsor:** Clear Scientific, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-07
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-06-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06316973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06316973, "A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06316973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
